Medicare Enrolled
Dr. Sung Ho Lee, M.D.
Hematology & Oncology · Nyack, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Sung Ho Lee is a hematology & oncology specialist in Nyack, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 2,957 Medicare services across 1,185 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $10,683 from 66 pharmaceutical and/or device companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 26% volume in NY
$10,683 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,957
Medicare services
Top 26% in NY for hematology & oncology
1,185
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,556 | $83 | $526 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
619 | $73 | $265 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
427 | $111 | $389 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $121 | $758 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
69 | $162 | $756 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
68 | $128 | $749 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
64 | $119 | $507 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $59 | $408 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,683
Total received (2018-2024)
Avg $1,526/year across 7 years
Top 24% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
516
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,170 (85.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,513 (14.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,231
2023
$768
2022
$593
2021
$628
2020
$1,527
2019
$2,823
2018
$3,115
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$190
ABBVIE INC.
$158
Eisai Inc.
$112
Janssen Biotech, Inc.
$99
E.R. Squibb & Sons, L.L.C.
$97
Ipsen Biopharmaceuticals, Inc
$96
Merck Sharp & Dohme LLC
$60
ARRAY BIOPHARMA INC
$50
Acrotech Biopharma Inc.
$50
Incyte Corporation
$49
Celgene Corporation
$40
Bayer Healthcare Pharmaceuticals Inc.
$39
EMD Serono, Inc.
$37
Sumitomo Pharma America, Inc.
$26
GlaxoSmithKline, LLC.
$26
Exelixis Inc.
$25
TAIHO ONCOLOGY, INC.
$23
Alexion Pharmaceuticals, Inc.
$21
Lilly USA, LLC
$19
Astellas Pharma US Inc
$15
Top 3 companies account for 37.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,742
AstraZeneca Pharmaceuticals LP
$1,006
Janssen Biotech, Inc.
$914
Genentech USA, Inc.
$586
PFIZER INC.
$551
Takeda Pharmaceuticals U.S.A., Inc.
$406
E.R. Squibb & Sons, L.L.C.
$369
Merck Sharp & Dohme Corporation
$365
Pharmacyclics LLC, An AbbVie Company
$346
Eisai Inc.
$293
Boehringer Ingelheim Pharmaceuticals, Inc.
$265
Alexion Pharmaceuticals, Inc.
$222
Incyte Corporation
$222
ABBVIE INC.
$196
ShockWave Medical, Inc
$194
Teva Pharmaceuticals USA, Inc.
$141
AngioDynamics, Inc.
$138
Ipsen Biopharmaceuticals, Inc
$129
Shockwave Medical, Inc
$129
Daiichi Sankyo Inc.
$123
Bayer HealthCare Pharmaceuticals Inc.
$122
Lilly USA, LLC
$120
GENZYME CORPORATION
$119
Gilead Sciences, Inc.
$105
EISAI INC.
$104
Merck Sharp & Dohme LLC
$91
Janssen Pharmaceuticals, Inc
$89
Acrotech Biopharma Inc.
$85
Welch Allyn
$79
Kite Pharma, Inc.
$73
Taiho Oncology, Inc.
$69
AMAG Pharmaceuticals, Inc.
$69
Puma Biotechnology, Inc.
$68
Astellas Pharma US Inc
$67
Helsinn Therapeutics (U.S.), Inc.
$67
Mirati Therapeutics, Inc.
$66
TAIHO ONCOLOGY, INC.
$61
Celgene Corporation
$58
Pharmacyclics LLC, an AbbVie Company
$56
Kyowa Kirin, Inc.
$56
Shire North American Group Inc
$55
AbbVie, Inc.
$53
ARRAY BIOPHARMA INC
$50
GlaxoSmithKline, LLC.
$46
Agios Pharmaceuticals, Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$39
Exelixis Inc.
$39
EMD Serono, Inc.
$37
Octapharma USA, Inc.
$31
CTI BioPharma Corp.
$29
Regeneron Healthcare Solutions, Inc.
$28
Seattle Genetics, Inc.
$26
Sumitomo Pharma America, Inc.
$26
Pharmacosmos Therapeutics Inc.
$23
TESARO, Inc.
$23
Integra LifeSciences Corporation
$21
AbbVie Inc.
$20
Jazz Pharmaceuticals Inc.
$18
Karyopharm Therapeutics Inc.
$18
Blueprint Medicines Corporation
$17
PORTOLA PHARMACEUTICALS, LLC
$16
Rigel Pharmaceuticals, Inc.
$15
Mylan Institutional Inc.
$15
Global Blood Therapeutics, Inc.
$14
Foundation Medicine, Inc.
$13
Seagen Inc.
$11
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ANDEXXA · AYVAKIT · Alecensa · Aliqopa · Aranesp · Auryon Laser System 100-120 Vac · Avastin · BELEODAQ · BENDEKA · CABOMETYX · CUVITRU · CYRAMZA · DARZALEX · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FASLODEX · FERAHEME · FOUNDATIONONE · Fulphila · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INVOKANA · Imbruvica · Integra · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LYNPARZA · Lenvima · Lonsurf · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · POTELIGEO · Perjeta · Pomalyst · Prolia · REBLOZYL · ROZLYTREK · RYBREVANT · Repatha · Revlimid · SANCUSO · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SOLIRIS · TAGRISSO · TALVEY · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VYXEOS · Vascular Lithotripsy · Vectibix · Venclexta · Vonjo · WILATE · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
483
Per 100K population
142.5
County median income
$110,631
Nearest hospital
NYACK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lee performed 1,556 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $10,683 from 66 companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other hematology & oncology specialists in Nyack?
Dr. Lee's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Nyack
Browse hematology & oncology specialists in Nyack ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology